House Energy & Commerce Subcommittee Issues Testimony From Pharmaceutical Research & Manufacturers VP Vereshchagina
May 10, 2022
May 10, 2022
WASHINGTON, May 10 -- The House Energy and Commerce Subcommittee on Health issued the following testimony by Lucy Vereshchagina, vice president for science and regulatory advocacy at Pharmaceutical Research and Manufacturers, involving a hybrid hearing on March 17, 2022, entitled "The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight":
* * *
My name is Lucy Vereshchagina, Vice President, Science and Regulatory Advocacy at the Pharma . . .
* * *
My name is Lucy Vereshchagina, Vice President, Science and Regulatory Advocacy at the Pharma . . .